China’s lapping us in biotech — but here’s how we can fight back

China has embraced CRISPR gene editing, leapfrogged the West in cell therapy, developed sophisticated animal models and expanded its biotech exports from near-zero in 2016 to nearly 30% of new assets in the world today .

If we don’t course-correct, we will cede the biotech future to China — and the Chinese Communist Party .

The FDA must recognize speed as an important goal of clinical research.

Millions of lives, and the world’s greatest engine of biotech innovation, hang in the balance. Joe Lonsdale is the co-founder of Palantir and managing partner of 8VC . Adapted from the Joe Lonsdale Substack ..